Literature DB >> 2665086

Pharmacology of ticlopidine: a review.

G Defreyn1, A Bernat, D Delebassee, J P Maffrand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2665086     DOI： 10.1055/s-2007-1002699

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN： 0094-6176            Impact factor:   4.180


× No keyword cloud information.
  12 in total

Review 1.  Antiplatelet therapy in interventional cardiology: I. Newer oral antiplatelet agents.

Authors:  F H Jafary; C D Kimmelstiel
Journal:  J Thromb Thrombolysis       Date:  2000-02       Impact factor: 2.300

Review 2.  Aspirin in patients with coronary artery disease: is it simply irresistible?

Authors:  G V Nair; C J Davis; M E McKenzie; D R Lowry; V L Serebruany
Journal:  J Thromb Thrombolysis       Date:  2001-04       Impact factor: 2.300

Review 3.  The human platelet fibrinogen receptor: clinical and therapeutic significance.

Authors:  M Cahill; R Mistry; D B Barnett
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

4.  Ticlopidine enhances the platelet inhibitory capacity of abciximab in vitro.

Authors:  N S Kleiman; N Graziadei; R E Jordan; E T Lance; A Fischer; K Maresh; A Edwards; M A Mascelli
Journal:  J Thromb Thrombolysis       Date:  2000-01       Impact factor: 2.300

Review 5.  Ticlopidine. An updated review of its pharmacology and therapeutic use in platelet-dependent disorders.

Authors:  D McTavish; D Faulds; K L Goa
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

Review 6.  Ticlopidine. A review of its pharmacology, clinical efficacy and tolerability in the prevention of cerebral ischaemia and stroke.

Authors:  S Noble; K L Goa
Journal:  Drugs Aging       Date:  1996-03       Impact factor: 3.923

Review 7.  Novel antithrombotic drugs in development.

Authors:  M Verstraete; P Zoldhelyi
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

Review 8.  Adverse haematological effects of ticlopidine. Prevention, recognition and management.

Authors:  B B Love; J Biller; M Gent
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606

9.  Antiplatelet treatment with cilostazol after stent implantation.

Authors:  Y Yoshitomi; S Kojima; T Sugi; M Yano; Y Matsumoto; M Kuramochi
Journal:  Heart       Date:  1998-10       Impact factor: 5.994

Review 10.  Antiplatelet drugs. A comparative review.

Authors:  K Schrör
Journal:  Drugs       Date:  1995-07       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.